Global Congress on Pharma Research and Drug Development
April 16-17, 2026 Tokyo, Japan
Smart Pharma: Integrating Technology and Therapeutics
About Global Congress on Pharma Research and Drug Development
Elevate Your Career — Attend the Conference to Secure Your CPD Credits
About the Conference
The Global Congress on Pharma Research and Drug Development, scheduled for April 16–17, 2026 in Tokyo, Japan, is an international platform dedicated to advancing pharmaceutical sciences and accelerating innovation in drug discovery. This congress brings together researchers, healthcare professionals, regulatory experts, and industry leaders to exchange insights on the latest breakthroughs shaping the future of global healthcare.
With the pharmaceutical sector rapidly evolving through AI-driven drug design, personalized medicine, biologics, nanotechnology, and precision drug delivery systems, the conference provides a unique opportunity to explore how these innovations are transforming patient care. Through keynote lectures, interactive panel discussions, workshops, and scientific sessions, participants will gain valuable knowledge while connecting with peers across academia, industry, and policy-making.
Beyond the science, the congress emphasizes the importance of collaboration, accessibility, and sustainability in pharma research. It aims not only to showcase cutting-edge discoveries but also to inspire partnerships that bridge the gap between laboratory research, clinical application, and global market access. Set in the vibrant city of Tokyo, the event combines world-class science with cultural exploration, making it an unmissable experience for anyone passionate about shaping the future of drug development.
Vision & Purpose
PharmaCon 2026 envisions a future where scientific innovation and collaborative partnerships accelerate the discovery of safer, more effective, and accessible therapies worldwide. The purpose of this congress is to unite researchers, clinicians, industry leaders, and policymakers on a single platform to exchange knowledge, address challenges in drug development, and drive forward breakthroughs in pharmaceuticals that improve patient outcomes and shape the future of global healthcare.
Why Attend?
The pharmaceutical industry is at a turning point—shaped by breakthroughs in genomics, AI-driven drug discovery, precision medicine, and regulatory advancements. This congress offers a platform for collaboration where scientists, clinicians, and industry pioneers come together to share insights, overcome challenges, and advance next-generation therapeutics.
Key Highlights
- Cutting-Edge Research: Explore the latest advances in drug discovery, formulation science, and pharmacology.
- Innovation in Action: Learn how AI, nanotechnology, and biotechnology are redefining pharmaceutical research.
- Global Networking: Connect with researchers, pharmaceutical companies, regulatory experts, and investors.
- Workshops & Panels: Hands-on discussions on clinical trials, regulatory landscapes, and market access strategies.
Who Should Attend?
- Pharma & Biotech Researchers
- Clinical Trial Specialists
- Regulatory Authorities & Policy Makers
- Healthcare Professionals & Clinicians
- Industry Executives & Investors
- Start-ups & Entrepreneurs in Drug Development
Impact & Takeaway
PharmaCon 2026 aims to be more than just a conference—it is a launchpad for innovation, a forum for collaboration, and a global stage for shaping the future of medicine. By participating, you will contribute to building a healthier, more accessible, and patient-centered pharmaceutical landscape.
Sessions/Tracks
-
AI-Driven Drug Discovery & Development
-
Virtual Screening, In Silico Trials & Digital Twins
-
Quantum Computing in Molecular Simulation
-
Precision Medicine & Targeted Therapies
-
Cell & Gene Therapies: Next-Generation Treatments
-
Oligonucleotide-Based Therapeutics (siRNA, ASOs, Aptamers)
-
Radioligand & Nuclear-Targeted Cancer Therapies
-
Protein Degradation & PROTAC Technology
-
Smart & Stimuli-Responsive Drug Delivery Systems
-
3D-Printed & Personalized Medicine
-
Nanomedicine & Silk Nanogel Drug Injectors
-
Remote-Controlled Synthetic Cells in Therapeutics
-
Decentralized & Digital Clinical Trials
-
Real-World Evidence (RWE) in Drug Approvals
-
AI & Big Data for Pharmacovigilance & Safety Monitoring
-
Blockchain & Smart Packaging for Drug Supply Chain Security
-
Green & Sustainable Pharma Manufacturing
-
Global Licensing Deals & Biotech Collaborations
-
Regulatory Innovation & Value-Based Drug Pricing
-
Future of Pharma: Integrating AI, Robotics & Automation
Important Dates
Abstract Submission Deadline
Date
March 16, 2026
Registration Deadline
Date
April 16, 2026
Full Paper Submission Deadline
Date
March 16, 2026
Event Venue
Advisory Committee
Testimonials
Media Partners